Conduction system pacing in heart failure: Time for a paradigm shift?
Heart Failure Reviews · 23.11.2024 · 30 (2) · 365-380
DOI: 10.1007/s10741-024-10469-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Heart Failure Reviews, online erschienen am 23.11.2024. Verfasst von Panayotis K Vlachakis und 15 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Cardiology, National and Kapodistrian University of Athens, School of Medicine "Hippokration" General Hospital, 114 Vasilissis So…. Hauptthemen laut MEDLINE: Heart Failure, Cardiac Pacing, Artificial, Heart Conduction System, Bundle of His. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 98 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF) is a major clinical challenge characterized by significant morbidity and mortality. Electrical conduction abnormalities play a critical role in HF pathophysiology and progression, often leading to suboptimal outcomes with conventional pacing techniques. Con-duction system pacing (CSP), encompassing His bundle pacing and left bundle branch area pacing, has emerged as a novel approach. Despite data come from observational studies, recent guidelines recommend that a specific population may benefit from CSP. However, significant practical considerations and challenges need to be clarified before CSP can be routinely implemented in clinical practice. The reliance on observational studies means that long-term clinical outcomes for HF patients remain uncertain until data from randomized controlled trials (RCTs) become available. Current CSP practices face challenges with lead implantation, mechanical stress on leads, and the need for more advanced tools and artificial intelligence integration to improve procedure efficacy and safety. Future large-scale RCTs are essential to identify optimal candidates and address these technical challenges, potentially leading to a paradigm shift in HF management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Department of Cardiology, National and Kapodistrian University of Athens, School of Medicine "Hippokration" General Hospital, 114 Vasilissis Sofias avenue, Athens, 11527, Greece. vlachakispanag@gmail.com.
- First Department of Cardiology, National and Kapodistrian University of Athens, School of Medicine "Hippokration" General Hospital, 114 Vasilissis Sofias avenue, Athens, 11527, Greece.
- State Department of Cardiology, "Hippokration" General Hospital of Athens, Athens, Greece.
- Department of Cardiology, University Hospital of Patras, Patras, Greece.
- Department of Cardiology, Northwell Health, New York, NY, USA.
- Ordensklinikum Linz Elisabethinen, Fadingerstraße 1, Linz, 4020, Austria.
Zitieren
APA
Vlachakis, P. K., Theofilis, P., Apostolos, A., Kordalis, A., Sideris, S., Leventopoulos, G., Mountantonakis, S. E., Kollias, G., Leontsinis, I., Drakopoulou, M., Karakasis, P., Tousoulis, D., Toutouzas, K., Tsiachris, D., Gatzoulis, K., & Tsioufis, C. (2024). Conduction system pacing in heart failure: Time for a paradigm shift?. Heart Failure Reviews, 30(2), 365-380. https://doi.org/10.1007/s10741-024-10469-9
Vancouver
Vlachakis PK, Theofilis P, Apostolos A, Kordalis A, Sideris S, Leventopoulos G, et al. Conduction system pacing in heart failure: Time for a paradigm shift?. Heart Failure Reviews. 2024;30(2):365-380. doi:10.1007/s10741-024-10469-9
BibTeX
@article{Vlachakis2024,
author = {Vlachakis, Panayotis K and Theofilis, Panagiotis and Apostolos, Anastasios and Kordalis, Athanasios and Sideris, Skevos and Leventopoulos, Georgios and Mountantonakis, Stavros E and Kollias, Georgios and Leontsinis, Ioannis and Drakopoulou, Maria and Karakasis, Paschalis and Tousoulis, Dimitrios and Toutouzas, Konstantinos and Tsiachris, Dimitrios and Gatzoulis, Konstantinos and Tsioufis, Costas},
title = {Conduction system pacing in heart failure: Time for a paradigm shift?},
journal = {Heart Failure Reviews},
year = {2024},
volume = {30},
number = {2},
pages = {365--380},
doi = {10.1007/s10741-024-10469-9}
}
EUVIMED